Santander UK fined $132M for poor AML controls
By 
Neil Hodge2022-12-09T20:39:00
The U.K. arm of Santander was fined approximately 107.8 million pounds (U.S. $132 million) by the country’s financial services regulator for “serious and persistent” gaps in its anti-money laundering (AML) controls.
Between December 2012 and October 2017, the accounts of more than 560,000 business customers were not checked properly due to repeated failings in Santander UK’s AML systems, the Financial Conduct Authority (FCA) said in a press release Friday.
Across six cases examined by the regulator, approximately £298 million (U.S. $366 million) of suspect funds were transferred in and out of business accounts before they were closed without triggering any warnings or requiring enhanced checks.
Related articles
-
News BriefReport: FCA probing Barclays over AML controls
Barclays Bank is reportedly being investigated by the U.K. Financial Conduct Authority for failures regarding its anti-money laundering procedures and controls.
-
ArticleLessons in preventing AML failures
Anybody working in financial services will know enormous effort is made to ensure their institution is on the right side of the law. Why, then, do such failures continue to exist? And crucially, what can be done to prevent their recurrence?
-
ArticleFCA fines Ghana International Bank $7.1M for AML failings
The U.K. Financial Conduct Authority fined Ghana International Bank £5.8 million (U.S. $7.1 million) for deficiencies in its anti-money laundering controls over its correspondent banking activities.
More from Regulatory Enforcement
-
News BriefCFPB drops $95M enforcement action against Navy Federal, without explanation
The Consumer Financial Protection Bureau has dropped a $95 million enforcement action against Navy Federal Credit Union, the latest regulatory pullback by the agency under President Donald Trump.
-
ArticleFCA drops ‘naming and shaming’ approach – except in ‘exceptional circumstances’
The UK’s financial regulator has had a rough ride over the past couple of years as its strategy to “name and shame” firms it opened investigations into was widely slammed by the industry and lawmakers over concerns that companies could be unfairly maligned.
-
News BriefDOJ targets $14.6B in health care fraud with focus on transnational crime
Emerging enforcement priorities of the U.S. Department of Justice’s health care fraud division align with the Trump administration’s emphasis on prosecuting transnational criminal organizations and ending opioid trafficking.